Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Cost-related nonadherence to medicines in people with multiple chronic conditions.

Laba TL, Cheng L, Kolhatkar A, Law MR.

Res Social Adm Pharm. 2019 Jun 20. pii: S1551-7411(19)30381-X. doi: 10.1016/j.sapharm.2019.06.008. [Epub ahead of print]

PMID:
31253501
2.

M-SAKHI-Mobile health solutions to help community providers promote maternal and infant nutrition and health using a community-based cluster randomized controlled trial in rural India: A study protocol.

Patel AB, Kuhite PN, Alam A, Pusdekar Y, Puranik A, Khan SS, Kelly P, Muthayya S, Laba TL, Almeida M, Dibley MJ.

Matern Child Nutr. 2019 Jun 8:e12850. doi: 10.1111/mcn.12850. [Epub ahead of print]

PMID:
31177631
3.

Cost-Related Underuse of Medicines for Asthma-Opportunities for Improving Adherence.

Laba TL, Jan S, Zwar NA, Roughead E, Marks GB, Flynn AW, Goldman MD, Heaney A, Lembke KA, Reddel HK.

J Allergy Clin Immunol Pract. 2019 Mar 27. pii: S2213-2198(19)30305-8. doi: 10.1016/j.jaip.2019.03.024. [Epub ahead of print]

PMID:
30928659
4.

Impact of a household-level deductible on prescription drug use among lower-income adults: a quasi-experimental study.

Law MR, Cheng L, Worthington H, Majumdar SR, McGrail KM, Chan F, Laba TL, Mamdani M.

CMAJ Open. 2019 Mar 29;7(1):E167-E173. doi: 10.9778/cmajo.20180198. Print 2019 Jan-Mar.

5.

Rapid and substantial increases in anticoagulant use and expenditure in Australia following the introduction of new types of oral anticoagulants.

Morgan A, Joshy G, Schaffer A, Laba TL, Litchfield M, Pearson S, Banks E.

PLoS One. 2018 Dec 6;13(12):e0208824. doi: 10.1371/journal.pone.0208824. eCollection 2018.

6.

Does a Patient-Directed Financial Incentive Affect Patient Choices About Controller Medicines for Asthma? A Discrete Choice Experiment and Financial Impact Analysis.

Laba TL, Reddel HK, Zwar NJ, Marks GB, Roughead E, Flynn A, Goldman M, Heaney A, Lembke K, Jan S.

Pharmacoeconomics. 2019 Feb;37(2):227-238. doi: 10.1007/s40273-018-0731-5.

PMID:
30367400
7.

Participant preferences for an Aboriginal-specific fall prevention program: Measuring the value of culturally-appropriate care.

Angell B, Laba T, Lukaszyk C, Coombes J, Eades S, Keay L, Ivers R, Jan S.

PLoS One. 2018 Aug 31;13(8):e0203264. doi: 10.1371/journal.pone.0203264. eCollection 2018.

8.

Process evaluation of a randomised controlled trial of a pharmacological strategy to improve hypertension control: protocol for a qualitative study.

Salam A, Webster R, Patel A, Godamunne P, Pathmeswaran A, de Silva HA, Rogers A, Jan S, Laba TL.

BMJ Open. 2018 Aug 17;8(8):e022317. doi: 10.1136/bmjopen-2018-022317.

9.

Medication non-adherence in a cohort of chronically ill Australians: A case of missed opportunities.

Laba TL, Lung T, Jan S, Scaria A, Usherwood T, Brien JA, A Plant N, Leeder S.

Aust J Gen Pract. 2018 Aug;47(8):556-562.

10.

Reaching cardiovascular prevention guideline targets with a polypill-based approach: a meta-analysis of randomised clinical trials.

Selak V, Webster R, Stepien S, Bullen C, Patel A, Thom S, Arroll B, Bots ML, Brown A, Crengle S, Dorairaj P, Elley CR, Grobbee DE, Harwood M, Hillis GS, Laba TL, Neal B, Peiris D, Rafter N, Reid C, Stanton A, Tonkin A, Usherwood T, Wadham A, Rodgers A.

Heart. 2019 Jan;105(1):42-48. doi: 10.1136/heartjnl-2018-313108. Epub 2018 Jun 28.

11.

General practitioners' views on the influence of cost on the prescribing of asthma preventer medicines: a qualitative study.

Tudball J, Reddel HK, Laba TL, Jan S, Flynn A, Goldman M, Lembke K, Roughead E, Marks GB, Zwar N.

Aust Health Rev. 2018 May 14. doi: 10.1071/AH17030. [Epub ahead of print]

PMID:
29754592
12.

Action to address the household economic burden of non-communicable diseases.

Jan S, Laba TL, Essue BM, Gheorghe A, Muhunthan J, Engelgau M, Mahal A, Griffiths U, McIntyre D, Meng Q, Nugent R, Atun R.

Lancet. 2018 May 19;391(10134):2047-2058. doi: 10.1016/S0140-6736(18)30323-4. Epub 2018 Apr 5. Review.

PMID:
29627161
13.

Cost-effectiveness of a fixed dose combination (polypill) in secondary prevention of cardiovascular diseases in India: Within-trial cost-effectiveness analysis of the UMPIRE trial.

Singh K, Crossan C, Laba TL, Roy A, Hayes A, Salam A, Jan S, Lord J, Tandon N, Rodgers A, Patel A, Thom S, Prabhakaran D.

Int J Cardiol. 2018 Jul 1;262:71-78. doi: 10.1016/j.ijcard.2018.03.082. Epub 2018 Mar 21.

14.

Patient Preferences for Managing Insomnia: A Discrete Choice Experiment.

Cheung JMY, Bartlett DJ, Armour CL, Saini B, Laba TL.

Patient. 2018 Oct;11(5):503-514. doi: 10.1007/s40271-018-0303-y.

PMID:
29502237
15.

Investigation of attributes which guide choice in cataract surgery services in urban Sydney, Australia.

Gilbert C, Keay L, Palagyi A, Do VQ, McCluskey P, White A, Carnt N, Stapleton F, Laba TL.

Clin Exp Optom. 2018 May;101(3):363-371. doi: 10.1111/cxo.12653. Epub 2018 Jan 17.

PMID:
29345003
16.

Considering pharmacy workflow in the context of Australian community pharmacy: A pilot time and motion study.

Cavaye D, Lehnbom EC, Laba TL, El-Boustani E, Joshi R, Webster R.

Res Social Adm Pharm. 2018 Dec;14(12):1157-1162. doi: 10.1016/j.sapharm.2018.01.003. Epub 2018 Jan 4.

PMID:
29317188
17.

Effectiveness of an electronic patient-centred self-management tool for gout sufferers: a cluster randomised controlled trial protocol.

Day RO, Frensham LJ, Nguyen AD, Baysari MT, Aung E, Lau AYS, Zwar N, Reath J, Laba T, Li L, McLachlan A, Runciman WB, Buchbinder R, Clay-Williams R, Coiera E, Braithwaite J, McNeil HP, Hunter DJ, Pile KD, Portek I, WIlliams KM, Westbrook JI.

BMJ Open. 2017 Oct 16;7(10):e017281. doi: 10.1136/bmjopen-2017-017281.

18.

Drivers of choice of resuscitation fluid in the intensive care unit: a discrete choice experiment.

Taylor CB, Hammond NE, Laba TL, Watts N, Thompson K, Saxena M, Micallef S, Finfer S, Myburgh J; FLUID TRIPS DCE.

Crit Care Resusc. 2017 Jun;19(2):134-141.

PMID:
28651509
19.

Healthcare expenditure on Indigenous and non-Indigenous Australians at high risk of cardiovascular disease.

Angell B, Laba TL, Lung T, Brown A, Eades S, Usherwood T, Peiris D, Billot L, Hillis G, Webster R, Tonkin A, Reid C, Molanus B, Rafter N, Cass A, Patel A, Jan S.

Int J Equity Health. 2017 Jun 23;16(1):108. doi: 10.1186/s12939-017-0610-2.

20.

A priority-setting framework is needed to understand the value of investing in a universal drug plan.

Laba TL, Mitton C.

CMAJ. 2017 May 15;189(19):E704. doi: 10.1503/cmaj.732990. No abstract available.

21.

Patient Perceptions of Treatment Delivery Platforms for Cognitive Behavioral Therapy for Insomnia.

Cheung JMY, Bartlett DJ, Armour CL, Laba TL, Saini B.

Behav Sleep Med. 2019 Jan-Feb;17(1):81-97. doi: 10.1080/15402002.2017.1293539. Epub 2017 Mar 21.

PMID:
28323439
22.

Using administrative data to look at changes in the level and distribution of out-of-pocket medical expenditure: An example using Medicare data from Australia.

Hua X, Erreygers G, Chalmers J, Laba TL, Clarke P.

Health Policy. 2017 Apr;121(4):426-433. doi: 10.1016/j.healthpol.2017.02.003. Epub 2017 Feb 23.

23.

Mapping the illness trajectories of insomnia: a biographical disruption?

Cheung JMY, Saini B, Bartlett DJ, Laba TL, Mason PH.

Sociol Health Illn. 2017 Jun;39(5):659-679. doi: 10.1111/1467-9566.12525. Epub 2016 Dec 7.

PMID:
27928829
24.

Making guidelines for economic evaluations relevant to public health in Australia.

Lung TW, Muhunthan J, Laba TL, Shiell A, Milat A, Jan S.

Aust N Z J Public Health. 2017 Apr;41(2):115-117. doi: 10.1111/1753-6405.12601. Epub 2016 Nov 20. No abstract available.

PMID:
27868297
25.

Creating a new investment pool for innovative health systems research.

Laba TL, Patel A, Jan S.

Aust Health Rev. 2017 May;41(2):173-175. doi: 10.1071/AH15230.

PMID:
27736634
26.

An integrated general practice and pharmacy-based intervention to promote the use of appropriate preventive medications among individuals at high cardiovascular disease risk: protocol for a cluster randomized controlled trial.

Hayek A, Joshi R, Usherwood T, Webster R, Kaur B, Saini B, Armour C, Krass I, Laba TL, Reid C, Shiel L, Hespe C, Hersch F, Jan S, Lo S, Peiris D, Rodgers A, Patel A.

Implement Sci. 2016 Sep 23;11(1):129.

27.

Examining the use of process evaluations of randomised controlled trials of complex interventions addressing chronic disease in primary health care-a systematic review protocol.

Liu H, Muhunthan J, Hayek A, Hackett M, Laba TL, Peiris D, Jan S.

Syst Rev. 2016 Aug 15;5(1):138. doi: 10.1186/s13643-016-0314-5.

28.

To Drug or Not to Drug: A Qualitative Study of Patients' Decision-Making Processes for Managing Insomnia.

Cheung JMY, Bartlett DJ, Armour CL, Laba TL, Saini B.

Behav Sleep Med. 2018 Jan-Feb;16(1):1-26. doi: 10.1080/15402002.2016.1163702. Epub 2016 May 18.

PMID:
27191585
29.

Interventions to improve medication adherence in coronary disease patients: A systematic review and meta-analysis of randomised controlled trials.

Santo K, Kirkendall S, Laba TL, Thakkar J, Webster R, Chalmers J, Chow CK, Redfern J.

Eur J Prev Cardiol. 2016 Jul;23(10):1065-76. doi: 10.1177/2047487316638501. Epub 2016 Mar 14. Review.

PMID:
26976848
30.

Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease: A Meta-analysis.

Thakkar J, Kurup R, Laba TL, Santo K, Thiagalingam A, Rodgers A, Woodward M, Redfern J, Chow CK.

JAMA Intern Med. 2016 Mar;176(3):340-9. doi: 10.1001/jamainternmed.2015.7667. Review.

PMID:
26831740
31.

Implementing Kanyini GAP, a pragmatic randomised controlled trial in Australia: findings from a qualitative study.

Liu H, Massi L, Eades AM, Howard K, Peiris D, Redfern J, Usherwood T, Cass A, Patel A, Jan S, Laba TL.

Trials. 2015 Sep 23;16:425. doi: 10.1186/s13063-015-0956-y.

32.

Financing options to sustain Medicare: are we committed to universalism?

Laba TL, Essue BM, Jan S.

Med J Aust. 2015 Sep 21;203(6):244-5.e1. No abstract available.

PMID:
26377286
33.

Facilitators and barriers to implementation of a pragmatic clinical trial in Aboriginal health services.

Liu H, Laba TL, Massi L, Jan S, Usherwood T, Patel A, Hayman NE, Cass A, Eades AM, Lawrence C, Peiris DP.

Med J Aust. 2015 Jul 6;203(1):24-7.

PMID:
26126563
34.

Patients' and providers' perspectives of a polypill strategy to improve cardiovascular prevention in Australian primary health care: a qualitative study set within a pragmatic randomized, controlled trial.

Liu H, Massi L, Laba TL, Peiris D, Usherwood T, Patel A, Cass A, Eades AM, Redfern J, Hayman N, Howard K, Brien JA, Jan S.

Circ Cardiovasc Qual Outcomes. 2015 May;8(3):301-8. doi: 10.1161/CIRCOUTCOMES.115.001483. Epub 2015 May 5.

PMID:
25944629
35.

Rational and design of a stepped-wedge cluster randomized trial evaluating quality improvement initiative for reducing cardiovascular events among patients with acute coronary syndromes in resource-constrained hospitals in China.

Li S, Wu Y, Du X, Li X, Patel A, Peterson ED, Turnbull F, Lo S, Billot L, Laba T, Gao R; CPACS-3 investigators.

Am Heart J. 2015 Mar;169(3):349-55. doi: 10.1016/j.ahj.2014.12.005. Epub 2014 Dec 18.

PMID:
25728724
36.

Patient preferences for a polypill for the prevention of cardiovascular diseases.

Laba TL, Howard K, Rose J, Peiris D, Redfern J, Usherwood T, Cass A, Patel A, Jan S.

Ann Pharmacother. 2015 May;49(5):528-39. doi: 10.1177/1060028015570468. Epub 2015 Feb 13.

PMID:
25680761
37.

An economic case for a cardiovascular polypill? A cost analysis of the Kanyini GAP trial.

Laba TL, Hayes A, Lo S, Peiris DP, Usherwood T, Hillis GS, Rafter N, Reid CM, Tonkin AM, Webster R, Neal BC, Cass A, Patel A, Rodgers A, Jan S.

Med J Aust. 2014 Dec 11;201(11):671-3.

PMID:
25495315
38.

The household economic burden of eating disorders and adherence to treatment in Australia.

Gatt L, Jan S, Mondraty N, Horsfield S, Hart S, Russell J, Laba TL, Essue B.

BMC Psychiatry. 2014 Nov 29;14:338. doi: 10.1186/s12888-014-0338-0.

39.

Understanding Patient Preferences in Medication Nonadherence: A Review of Stated Preference Data.

Laba TL, Essue B, Kimman M, Jan S.

Patient. 2015 Oct;8(5):385-95. doi: 10.1007/s40271-014-0099-3. Review.

PMID:
25404203
40.

Co-payments for health care: what is their real cost?

Laba TL, Usherwood T, Leeder S, Yusuf F, Gillespie J, Perkovic V, Wilson A, Jan S, Essue B.

Aust Health Rev. 2015 Feb;39(1):33-36. doi: 10.1071/AH14087.

PMID:
25362348
41.

Can A Cvd Polypill Save Money In The 'Real World'?

Laba TL, Hayes A, Jan S, Rodgers A, Patel A, Cass A, Reid C, Tonkin A, Usherwood T, Webster R.

Value Health. 2014 Nov;17(7):A482. doi: 10.1016/j.jval.2014.08.1398. Epub 2014 Oct 26. No abstract available.

42.

Evaluating the costs and benefits of using combination therapies.

Rodgers A, Laba TL, Jan S.

Med J Aust. 2014 Oct 20;201(8):447-8. No abstract available.

PMID:
25332026
43.
44.

Understanding if, how and why non-adherent decisions are made in an Australian community sample: a key to sustaining medication adherence in chronic disease?

Laba TL, Lehnbom E, Brien JA, Jan S.

Res Social Adm Pharm. 2015 Mar-Apr;11(2):154-62. doi: 10.1016/j.sapharm.2014.06.006. Epub 2014 Jul 20.

PMID:
25103184
45.

INterpreting the Processes of the UMPIRE Trial (INPUT): protocol for a qualitative process evaluation study of a fixed-dose combination (FDC) strategy to improve adherence to cardiovascular medications.

Salam A, Stewart F, Singh K, Thom S, Williams HJ, Patel A, Jan S, Laba T, Prabhakaran D, Maulik P, Day S, Ward H.

BMJ Open. 2013 May 28;3(5). pii: e002313. doi: 10.1136/bmjopen-2012-002313.

46.

Patient preferences for adherence to treatment for osteoarthritis: the MEdication Decisions in Osteoarthritis Study (MEDOS).

Laba TL, Brien JA, Fransen M, Jan S.

BMC Musculoskelet Disord. 2013 May 6;14:160. doi: 10.1186/1471-2474-14-160.

47.

Strategies to improve adherence to medications for cardiovascular diseases in socioeconomically disadvantaged populations: a systematic review.

Laba TL, Bleasel J, Brien JA, Cass A, Howard K, Peiris D, Redfern J, Salam A, Usherwood T, Jan S.

Int J Cardiol. 2013 Sep 10;167(6):2430-40. doi: 10.1016/j.ijcard.2013.01.049. Epub 2013 Feb 13. Review.

PMID:
23415168
48.

Understanding rational non-adherence to medications. A discrete choice experiment in a community sample in Australia.

Laba TL, Brien JA, Jan S.

BMC Fam Pract. 2012 Jun 20;13:61. doi: 10.1186/1471-2296-13-61.

49.

What determines adherence to treatment in cardiovascular disease prevention? Protocol for a mixed methods preference study.

Jan S, Usherwood T, Brien JA, Peiris D, Rose J, Hayman N, Howard K, Redfern J, Laba T, Cass A, Patel A.

BMJ Open. 2011 Jan 1;1(2):e000372. doi: 10.1136/bmjopen-2011-000372.

Supplemental Content

Support Center